Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial.
Diane Purper-OuakilHilario Blasco-FontecillaTomas RosEric AcquavivaTobias BanaschewskiSarah BaumeisterElisa BousquetAurore BussalbMarie DelhayeRichard DelormeRenate DrechslerAllison GoujonAlexander HägeAnna KaiserLouis MayaudKonstantin MechlerCaroline MenacheOlivier RevolFriederike TagwerkerSusanne WalitzaAnna Maria WerlingStephanie BioulacDaniel BrandeisPublished in: Journal of child psychology and psychiatry, and allied disciplines (2021)
Based on clinicians' reports, the effects of at-home NF were inferior to those of methylphenidate as a stand-alone treatment.
Keyphrases
- attention deficit hyperactivity disorder
- phase iii
- phase ii
- autism spectrum disorder
- open label
- double blind
- clinical trial
- signaling pathway
- young adults
- study protocol
- working memory
- palliative care
- placebo controlled
- oxidative stress
- lps induced
- randomized controlled trial
- nuclear factor
- pi k akt
- combination therapy
- cell proliferation
- replacement therapy
- smoking cessation